NICE Upholds Rejection of Expensive Cancer Drug as Calls for Flexible Drug Pricing Models Grow
The National Institute for Health and Care Excellence (NICE) has rejected Zytiga for the second time. Despite evidence that the [...]
New Report Notes 65 Prescription Drug Increases in July 2021, 800 in January
65 drugs have increased in price this month by approximately 3.5%. GoodRx identified drug manufacturers, which include Pfizer, Bristol Myers [...]
Pelosi Seeks Prescription Drug Pricing Legislation Including Medicare Negotiation as House Report Notes Pharma Spent $577 Billion on Stock Buybacks and Dividends
House Speaker Nancy Pelosi announced she will push for drug pricing legislation to be included in President Biden’s economic budget, [...]
Moderate Democrats Singled Out by Targeted Drug Pricing Ads
Ad campaigns supporting drug pricing reform are being launched in states with moderate Democrats who may vote against healthcare legislation [...]
Pfizer Heart Failure Medication Lawsuit Ruling Could Broadly Impact Medicare, Lead to Expensive Aduhelm Coverage
Pfizer is seeking legal backing for its plan to pay healthcare costs for Medicare patients taking one of its pricy [...]
Cigna Incentive Program Offers $500 to Switch from Biologics to Biosimilars, Drug Savings Could Reach $375 Billion
In an effort to promote biosimilars, Cigna is offering $500 if customers switch to a lower-cost offering. Experts project that [...]
JAMA Article Finds Medicare Overspent on Generics by $2.6 Billion, Costco Delivered Better Value
A recent article published in JAMA Internal Medicine compares Medicare drug spending on generics to Costco. The researchers found that [...]
2021 Managed Healthcare Executive Pharmacy Survey Respondents Consider Impact of Federal Legislation on Drug Prices
The final portion of Managed Healthcare Executive’s 2021 Pharmacy Survey focused on federal legislation as a mechanism to reduce prescription [...]
CEVR Researcher and Author Dan Ollendorf Discusses QALYs, Reducing Prescription Drug Prices Using Value, and HTAs
Dr. Dan Ollendorf of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts University Medical [...]
Will Senate Finance Committee Chair Use Domestic Reference Pricing in Prescription Drug Negotiation Plan?
Allowing Medicare to negotiate prescription drug costs is one method of reducing healthcare costs. Now, Senate Finance Committee Chair Ron [...]
Prescription Drug Prices Increased 3.1% in July 2020 According to GoodRx
GoodRx found that 52 drugs rose in price by 3.1% in July 2020, while no generics upped their prices. Zogenix’s [...]
Vanderbilt and Stanford Professors Discuss 2021 Drug Pricing Reform in JAMA Article, Note Power of Value Assessments and Medicare Negotiation During COVID-19 Pandemic
Dr. Stacie Dusetzina of Vanderbilt University School of Medicine and Dr. Michelle Mello of Stanford Law School and Stanford School [...]
ICER Considers Fair Access Principles as Aduhelm Price Continues to Incense Critics
The Institute for Clinical and Economic Review (ICER) recently published its protocol detailing how it will gauge access to prescription [...]
Despite WHO Recommendation, COVID-19 Drug Too Costly and Inaccessible; Will Roche Give Up Monopoly?
The World Health Organization (WHO) has recommended the use of monoclonal antibody tocilizumab in cases of severe COVID-19 illness. However, [...]
2021 Managed Healthcare Executive Pharmacy Survey Results Include Increased Focus on Price Transparency to Reduce Prescription Drug Costs
Managed Healthcare Executive is publishing the results from its recent survey. According to the more than 225 respondents, reducing drug [...]
Interview with University of Washington Professor and Dean Sheds Light on Reimbursing Novel Cell and Gene Therapies
The Evidence Base interviewed the University of Washington’s Sean Sullivan on the intricacies of reimbursement for novel therapies. Although these [...]
Walmart Enters Insulin Industry Amid Criticism
Walmart has announced that it will sell a cheaper version of insulin. Although this move is projected to pass substantial [...]
Supreme Court to Hear Hospital Drug Pricing Case in Medicare Test
The Supreme Court will hear a case on Medicare drug price determination. This is one of many tests of healthcare [...]
Webinar on Value-Based Pricing Now Available On-Demand
Authors of a recently released book on drug pricing, The Right Price: A Value-Based Prescription for Drug Costs, hosted a webinar [...]
Cigna’s New Shared Savings Program Offers $500 if Members Convert to Biosimilars as Billion Dollar Savings Loom
Cigna has launched a Shared Savings Program, aimed at reducing costs for its members by identifying alternative drugs offered at [...]
Biogen’s Aduhelm Brings Uncertainty and Concern Regarding Federal Budget
The FDA recently approved Biogen’s Aduhelm for use in patients with Alzheimer’s disease. However, its high price tag—$56,000—means that many [...]
Alzheimer’s Drug Could Equal Federal Government’s Spending on NASA
Biogen’s Aduhelm is exceedingly expensive at $56,000. If covered under Medicare, its cost could approach the federal government’s spending on [...]
Biogen Considers Aduhelm Price Cut as Competing Alzheimer’s Drug Approved by FDA
Biogen and its partner Eisai released a statement regarding Alzheimer’s Drug Aduhelm, which is priced at $56,000 per year. The [...]
CVS Eliminates 72 Hyperinflated Drugs, Saving $1.2 Billion in 2020
CVS has removed 72 high-priced drugs from its formulary. This move has led to $1.2 billion in savings last year [...]
Five Blue Cross Blue Shield Health Insurance Plans to Incorporate Evio to Cut Costs
Five Blue Cross Blue Shield insurance plans will utilize Evio to reduce healthcare costs, including high prescription drug costs. This [...]